| Date Initiated by Firm | June 26, 2026 |
| Date Posted | August 04, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-2880-2026 |
| Recall Event ID |
99379 |
| 510(K)Number | K801204 |
| Product Classification |
Enzyme immunoassay, lidocaine - Product Code KLR
|
| Product | Syva Emit Disopyramide Assay
Enzyme Immunoassay, Lidocaine
SMN 10445370
Catalog No 6N319UL |
| Code Information |
UDI-DI 00842768001406
Lot U1 |
| FEI Number |
2517506
|
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 500 Gbc Dr Newark DE 19702-2466
|
| For Additional Information Contact | Louise Mclaughlin 800-441-9250 |
Manufacturer Reason for Recall | Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On 6/26/2026, Siemens issued Urgent Medical Device Correction letters to all affected customers informing them of the issue and providing instructions.
Customers are instructed to refer to the SDS which were created and provided with the
Urgent Medical Device Corrections and the Urgent Field Safety Notices specifically for
Syva Emit Disopyramide Assay Lot U1 for information regarding handling and disposal. |
| Quantity in Commerce | 8 US; 44 OUS |
| Distribution | Worldwide - US Nationwide distribution in the states of CA and VA. The country of Japan. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = KLR
|